Raymond James Financial’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Raymond James Financial's DYN Position: Q3 2026 in Review
Raymond James Financial reduced its Dyne Therapeutics (DYN) stake by 5.6% in Q3 2026, selling an estimated $739K and leaving 544,188 shares worth $8.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.
Raymond James Financial first reported a position in DYN in Q4 2024 and has held it in 8 quarters since. The position peaked at $12.8M in Q2 2026. 205 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Raymond James Financial held 544,188 shares of Dyne Therapeutics worth $8.77M as of Q3 2026.
- Raymond James Financial sold 32,162 Dyne Therapeutics shares in Q3 2026, an estimated $739K.
- Dyne Therapeutics made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2266 holding.
- Raymond James Financial first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Dyne Therapeutics position peaked at $12.8M in Q2 2026.
- 205 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.